메뉴 건너뛰기




Volumn 28, Issue 11, 1999, Pages 1070-1072

Symptomatic sinus bradycardia associated with donepezil;Bradicardia sinusal sintomatica asociada a donepecilo

Author keywords

Alzheimer's disease; Bradycardia; Dementia; Donepezil

Indexed keywords

DONEPEZIL; CHOLINESTERASE INHIBITOR; INDAN DERIVATIVE; PIPERIDINE DERIVATIVE;

EID: 0033144481     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.2811.99025     Document Type: Article
Times cited : (27)

References (18)
  • 1
    • 0017652462 scopus 로고
    • Memory and cognitive function in man: Does the cholinergic system have a specific role?
    • Drachman DA. Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 1977; 27: 783-90.
    • (1977) Neurology , vol.27 , pp. 783-790
    • Drachman, D.A.1
  • 2
    • 0011162190 scopus 로고
    • Selective loss of central cholinergic neurons in Alzheimer's disease
    • Davies P, Maloney AJ. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976; 2: 1403.
    • (1976) Lancet , vol.2 , pp. 1403
    • Davies, P.1    Maloney, A.J.2
  • 3
    • 0020686674 scopus 로고
    • Alzheimer's disease: A disorder of cholinergic innervation
    • Coyle JT, Price DL, DeLong MR. Alzheimer's disease: a disorder of cholinergic innervation. Science 1983; 219: 1184-90.
    • (1983) Science , vol.219 , pp. 1184-1190
    • Coyle, J.T.1    Price, D.L.2    DeLong, M.R.3
  • 4
    • 0032296920 scopus 로고    scopus 로고
    • Tratamiento médico de la enfermedad de Alzheimer
    • López-Pousa S, Serra-Mestres J. Tratamiento médico de la enfermedad de Alzheimer. Rev Neurol 1998; 26: 1054-60.
    • (1998) Rev Neurol , vol.26 , pp. 1054-1060
    • López-Pousa, S.1    Serra-Mestres, J.2
  • 5
    • 0022966837 scopus 로고
    • Cell loss from the nucleus basalis of Meynert in Alzheimer's disease
    • Doucette R, Fisman M, Hachinski VC, Mersky H. Cell loss from the nucleus basalis of Meynert in Alzheimer's disease. Can J Neurol Sci 1986; 13: 435-40.
    • (1986) Can J Neurol Sci , vol.13 , pp. 435-440
    • Doucette, R.1    Fisman, M.2    Hachinski, V.C.3    Mersky, H.4
  • 6
    • 0018078940 scopus 로고
    • Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
    • Perry EK, Tomlinson BE, Blessed G, Bergman K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978; 2: 1457-9.
    • (1978) Br Med J , vol.2 , pp. 1457-1459
    • Perry, E.K.1    Tomlinson, B.E.2    Blessed, G.3    Bergman, K.4    Gibson, P.H.5    Perry, R.H.6
  • 7
    • 0028238408 scopus 로고
    • Emerging drugs for Alzheimer's disease: Mechanisms of actions and prospects for cognitive enhancing medications
    • Schneider LS, Tariot PN. Emerging drugs for Alzheimer's disease: mechanisms of actions and prospects for cognitive enhancing medications. Med Clin North Am 1994; 78: 911-34.
    • (1994) Med Clin North Am , vol.78 , pp. 911-934
    • Schneider, L.S.1    Tariot, P.N.2
  • 8
    • 0022899577 scopus 로고
    • Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer type
    • Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia Alzheimer type. N Engl J Med 1986; 315: 1241-5.
    • (1986) N Engl J Med , vol.315 , pp. 1241-1245
    • Summers, W.K.1    Majovski, L.V.2    Marsh, G.M.3    Tachiki, K.4    Kling, A.5
  • 9
    • 0028270519 scopus 로고
    • A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease
    • Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davies CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. JAMA 1994; 271: 985-91.
    • (1994) JAMA , vol.271 , pp. 985-991
    • Knapp, M.J.1    Knopman, D.S.2    Solomon, P.R.3    Pendlebury, W.W.4    Davies, C.S.5    Gracon, S.I.6
  • 10
    • 0028198828 scopus 로고
    • Tacrine: First drug approved for Alzheimer's disease
    • Crismon ML. Tacrine: first drug approved for Alzheimer's disease. Ann Pharmacother 1994; 28: 744-51.
    • (1994) Ann Pharmacother , vol.28 , pp. 744-751
    • Crismon, M.L.1
  • 11
    • 10244259208 scopus 로고    scopus 로고
    • The efficacy and safety of donepezil in patients with Alzheimer's disease: Re-suits of a US multicenter, randomized, double-blind, placebo-controlled trial
    • Rogers SL, Friedhoff LT, and The Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer's disease: re-suits of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia 1996; 7: 293-303.
    • (1996) Dementia , vol.7 , pp. 293-303
    • Rogers, S.L.1    Friedhoff, L.T.2
  • 12
    • 0032507788 scopus 로고    scopus 로고
    • Donepezil improves cognition and global function in Alzheimer disease: A 15-week, doubled-blind, placebo-controlled study
    • Donepezil Study Group
    • Rogers SL, Doody RS, Mohs RC, Friedhoff LT. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, doubled-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med 1998; 158: 1021-31.
    • (1998) Arch Intern Med , vol.158 , pp. 1021-1031
    • Rogers, S.L.1    Doody, R.S.2    Mohs, R.C.3    Friedhoff, L.T.4
  • 13
    • 0031883716 scopus 로고    scopus 로고
    • A 24-week, double blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease
    • Donepezil Study Group
    • Rogers SL, Farlow MR, Doody RS, Mohs RC, Friedhoff LT. A 24-week, double blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology 1998; 50: 136-45.
    • (1998) Neurology , vol.50 , pp. 136-145
    • Rogers, S.L.1    Farlow, M.R.2    Doody, R.S.3    Mohs, R.C.4    Friedhoff, L.T.5
  • 14
    • 0028823072 scopus 로고
    • Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-((5,6-dimethoxy-1-oxoindan-2-ye)methyl)piperidine hydrochloride and related compounds
    • Sugimoto H, limura Y, Yamanishi Y, Yamatsu K. Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-((5,6-dimethoxy-1-oxoindan-2-ye)methyl)piperidine hydrochloride and related compounds. J Med Chem 1995; 38: 4821-9.
    • (1995) J Med Chem , vol.38 , pp. 4821-4829
    • Sugimoto, H.1    Limura, Y.2    Yamanishi, Y.3    Yamatsu, K.4
  • 15
    • 0031910978 scopus 로고    scopus 로고
    • Donepezil use in Alzheimer disease
    • Barner EL, Gray SL. Donepezil use in Alzheimer disease. Ann Pharmacother 1998; 32: 70-7.
    • (1998) Ann Pharmacother , vol.32 , pp. 70-77
    • Barner, E.L.1    Gray, S.L.2
  • 16
    • 0000857096 scopus 로고    scopus 로고
    • Physiology and pharmacology of the autonomic nervous system
    • Fauci AS, Braunwald E, eds. New York: McGraw-Hill
    • Landsberg L, Young JB. Physiology and pharmacology of the autonomic nervous system. In Fauci AS, Braunwald E, eds. Harrison's principles of internal medicine. New York: McGraw-Hill; 1998. p. 430-42.
    • (1998) Harrison's Principles of Internal Medicine , pp. 430-442
    • Landsberg, L.1    Young, J.B.2
  • 18
    • 0027141935 scopus 로고
    • Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly patients
    • Ohnishi A, Mihara M, Kamakura H, Tomono Y, Hasegawa J, Yamazaki K, et al. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly patients. J Clin Pharmacol 1993; 33: 1086-91.
    • (1993) J Clin Pharmacol , vol.33 , pp. 1086-1091
    • Ohnishi, A.1    Mihara, M.2    Kamakura, H.3    Tomono, Y.4    Hasegawa, J.5    Yamazaki, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.